Skip to main content
. 2020 Aug 6;13:2689–2698. doi: 10.2147/IDR.S258420

Table 4.

Risk of Poststroke Pneumonia According to Statin Intensity

Statin therapy Adjusted HR (95% CI) p-value p-value for trend
No use of statins 1 (ref) 0.004
Current use of low- to intermediate-intensity statins 0.88 (0.78–0.99) 0.038
Current use of high-intensity statins 0.49 (0.27–0.87) 0.015

Note: Data derived from multivariate time-dependent Cox proportional hazard–regression model adjusted for the variables listed in Table 3.